Tag archive for ‘Multiple Myeloma’
Globes On Sunday, July 14th, 2013

XTL Bio returns to Nasdaq

– XTL’s lead product is a treatment of multiple myeloma, and it is readying a clinical trial for the product. – / By Gali Weinreb /  XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB); TASE:XTL) More...

Contributor On Thursday, June 20th, 2013

Israeli Cancer Vaccine: ImMucin shows optimistic results

– From right: CEO Dr. Lior Carmon, and Julian Levy , President and CFO – /By Jewish Business News Service / Cancer is one of the biggest challenges of the 21st Centuries. Although treatments More...

Wordpress site Developed by Fixing WordPress Problems